Beam Therapeutics (BEAM) Other financing activities (2019 - 2026)
Beam Therapeutics (BEAM) reported Other financing activities of $813000.0 for Q1 2026, up 111.72% on a QoQ basis from $384000.0 in Q3 2023.
Beam Therapeutics (BEAM) has 6 years of Other financing activities data on file, last reported at $813000.0 in Q1 2026.
- Quarterly Other financing activities changed N/A year-over-year to $813000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 110.37% YoY) and the FY2023 annual result came in at $631000.0, up 235.64% from the prior year.
- Other financing activities grew to $813000.0 in Q1 2026 per BEAM's latest filing, from $384000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $813000.0 in Q1 2026 and bottomed at $6000.0 in Q1 2022.
- The 3-year median for Other financing activities is $82500.0 (2022), against an average of $204000.0.
- The widest annual swing landed in 2022, when Other financing activities sank 99.92%; it then surged 1436.0% in 2023.
- Tracing BEAM's Other financing activities over 3 years: stood at $54000.0 in 2022, then soared by 611.11% to $384000.0 in 2023, then jumped by 111.72% to $813000.0 in 2026.
- Per Business Quant, the three latest BEAM Other financing activities figures stand at $813000.0 (Q1 2026), $384000.0 (Q3 2023), and $185000.0 (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Beam Therapeutics | 3.40 Bn | 3.40 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 813,000.00 |
| Mar 31, 2026 | 813,000.00 |
| Sep 30, 2023 | 384,000.00 |
| Sep 30, 2023 | 384,000.00 |
| Jun 30, 2023 | 185,000.00 |
| Jun 30, 2023 | 185,000.00 |
| Mar 31, 2023 | 62,000.00 |
| Mar 31, 2023 | 62,000.00 |
| Dec 31, 2022 | 54,000.00 |
| Dec 31, 2022 | 54,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Jun 30, 2022 | 103,000.00 |
| Jun 30, 2022 | 103,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 128,000.00 |
| Dec 31, 2021 | 128,000.00 |
| Sep 30, 2021 | 209,000.00 |
| Sep 30, 2021 | 209,000.00 |
| Jun 30, 2021 | 524,000.00 |
| Jun 30, 2021 | 524,000.00 |
| Mar 31, 2021 | 7.96 Mn |
| Mar 31, 2021 | 7.96 Mn |
| Dec 31, 2020 | 342,000.00 |
| Dec 31, 2020 | 342,000.00 |
| Sep 30, 2020 | 52,000.00 |
| Sep 30, 2020 | 52,000.00 |
| Jun 30, 2020 | 707,000.00 |
| Jun 30, 2020 | 707,000.00 |
| Mar 31, 2020 | 958,000.00 |
| Mar 31, 2020 | 958,000.00 |
| Dec 31, 2019 | 1.43 Mn |
| Dec 31, 2019 | 1.43 Mn |
| Sep 30, 2019 | 1.02 Mn |
| Sep 30, 2019 | 1.02 Mn |